Hereditary angioedema: A case report

• Autores: A Ramón Albert, Rodrigo Bonilla Peñarrubia, Carlos Devesa García, Amparo Soria Aledo, Pedro García Salom
• Localización: European journal of clinical pharmacy: atención farmacéutica, ISSN 2385-409X, Vol. 18, Nº. 2, 2016, págs. 126-129
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Introduction: Hereditary angioedema (HAE) is a genetic disease caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH) characterized by recurrent episodes of angioedema, affecting multiple anatomic locations. Both phenotypic variability and the unpredictability of frequency of HAE attacks are due to inaccurate and/or delayed diagnoses.

    A Case report: We describe the case of a 50-year-old patient, who after several episodes of angioedema (mainly on hands and face), is diagnosed with HAE type I. She required urgent treatment with C1-INH concentrates in two occasions. Finally, the patient was set-up for long-term prophylactic therapy with stanozolol.

    Conclusion: An early and accurate diagnosis of the disease leads to optimal therapeutic interventions that entail an improvement in the quality of life of patients with HAE